Hirofumi Kai
Impact in
- Immunology top 2%
- Immune Response and Inflammation
- Immune Cell Function and Interaction
- Microbiology top 2%
Papers in
-
- Glycosylation and Glycoproteins Research 15
- Heat shock proteins research 12
-
- Neonatal Respiratory Health Research 24
- Cystic Fibrosis Research Advances 22
- Respiratory and Cough-Related Research 14
- Co-authors
- Tsuyoshi Shuto (114 shared papers)Mary Ann Suico (108 shared papers)Jiandong Li (29 shared papers)Hirofumi Jono (14 shared papers)Tomoaki Koga (29 shared papers)Haidong Xu (8 shared papers)Takashi Sato (30 shared papers)Yoichiro Isohama (34 shared papers)
- Journals
- Journal of Biological Chemistry (21 papers)Biochemical and Biophysical Research Communications (17 papers)Journal of Pharmacological Sciences (13 papers)Biological and Pharmaceutical Bulletin (6 papers)Scientific Reports (5 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Hirofumi Kai
217 papers receiving 4.9k citations
Peers
Comparison fields: 5 of 130
- Immunology 1.3k
- Microbiology 234
- Cancer Research 487
- Cell Biology 494
- Molecular Biology 2.0k
Countries citing papers authored by Hirofumi Kai
This map shows the geographic impact of Hirofumi Kai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirofumi Kai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirofumi Kai more than expected).
Fields of papers citing papers by Hirofumi Kai
This network shows the impact of papers produced by Hirofumi Kai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirofumi Kai. The network helps show where Hirofumi Kai may publish in the future.
Co-authors
The 25 scholars most cited alongside Hirofumi Kai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 226 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 232 | |
| 2 | 2005 | 161 | |
| 3 | 2007 | 139 | |
| 4 | 2002 | 136 | |
| 5 | 2002 | 120 | |
| 6 | 2008 | 102 | |
| 7 | 2015 | 99 | |
| 8 | 2006 | 93 | |
| 9 | 2002 | 89 | |
| 10 | 2010 | 85 | |
| 11 | 2003 | 84 | |
| 12 | 2003 | 82 | |
| 13 | 2010 | 82 | |
| 14 | 2007 | 75 | |
| 15 | 2005 | 74 | |
| 16 | 1996 | 74 | |
| 17 | 2015 | 73 | |
| 18 | 1994 | 73 | |
| 19 | 2012 | 64 | |
| 20 | The ETS transcription factor MEF is a candidate tumor suppressor gene on the X chromosome. | 2002 | 63 |
About Hirofumi Kai
Hirofumi Kai is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Immunology, Physiology and Cell Biology, having authored 226 papers that have together received 5.0k indexed citations. Recurring topics across this work include Neonatal Respiratory Health Research (24 papers), Cystic Fibrosis Research Advances (22 papers), Immune Response and Inflammation (20 papers), Asthma and respiratory diseases (16 papers), Endoplasmic Reticulum Stress and Disease (16 papers), Glycosylation and Glycoproteins Research (15 papers), Respiratory and Cough-Related Research (14 papers) and Heat shock proteins research (12 papers). The work is most often cited by research in Immunology (1.3k citations), Microbiology (234 citations), Cancer Research (487 citations), Cell Biology (494 citations) and Molecular Biology (2.0k citations). Hirofumi Kai has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Tsuyoshi Shuto, Mary Ann Suico, Jiandong Li, Hirofumi Jono, Tomoaki Koga, Haidong Xu, Takashi Sato, Yoichiro Isohama, Takeshi Miyata and David Lim. Their work appears in journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications, Journal of Pharmacological Sciences, Biological and Pharmaceutical Bulletin and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.